Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
Lisa H. Butterfield, Yana G. Najjar
Nature reviews. Immunology (2023) Vol. 24, Iss. 6, pp. 399-416
Closed Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Targeting KRAS: from metabolic regulation to cancer treatment
Yanyan Shi, Huiling Zheng, Tianzhen Wang, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion
Ankita Mitra, Anoop Kumar, Nitin Amdare, et al.
Biology (2024) Vol. 13, Iss. 5, pp. 307-307
Open Access | Times Cited: 9
M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets
Mengzhen Han, Qibo Huang, Xinxin Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1238-1255
Open Access | Times Cited: 8
Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities
Jessica Konen, Haoyi Wu, Don L. Gibbons
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 520-536
Closed Access | Times Cited: 8
YAP1 Inhibition Induces Phenotype Switching of Cancer-Associated Fibroblasts to Tumor Suppressive in Prostate Cancer
Hongtao Song, Tong Lü, Donghui Han, et al.
Cancer Research (2024) Vol. 84, Iss. 22, pp. 3728-3742
Open Access | Times Cited: 8
Manganese Galvanic Cells Intervene in Tumor Metabolism to Reinforce cGAS‐STING Activation for Bidirectional Synergistic Hydrogen‐Immunotherapy
Nailin Yang, Shumin Sun, Jiachen Xu, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 1
Editorial: High Baseline ALT Level Confers Risk of Hepatic Adverse Events During Immune Checkpoint Inhibitors Treatment—A Call for Caution
Zehua Zhao, Yu‐Chen Fan
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 1
Plant-derived Pembrolizumab in conjugation with IL-15Rα-IL-15 complex shows effective anti-tumor activity
Kaewta Rattanapisit, Pipob Suwanchaikasem, Christine Joy I. Bulaon, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316790-e0316790
Open Access | Times Cited: 1
Self-Cascaded Pyroptosis-STING Initiators for Catalytic Metalloimmunotherapy
Qiao Yu, Shumin Sun, Nailin Yang, et al.
Journal of the American Chemical Society (2025)
Closed Access | Times Cited: 1
Emerging Role of Extracellular pH in Tumor Microenvironment as a Therapeutic Target for Cancer Immunotherapy
Md. Ataur Rahman, Mahesh Kumar Yadab, Meser M. Ali
Cells (2024) Vol. 13, Iss. 22, pp. 1924-1924
Open Access | Times Cited: 7
PTMs of PD-1/PD-L1 and PROTACs application for improving cancer immunotherapy
Xiaohui Ren, Lijuan Wang, Likun Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Next-generation combination approaches for immune checkpoint therapy
Sangeeta Goswami, Kristen E. Pauken, Linghua Wang, et al.
Nature Immunology (2024) Vol. 25, Iss. 12, pp. 2186-2199
Closed Access | Times Cited: 6
Targeted inhibition of the PI3K/AKT/mTOR pathway by (+)-anthrabenzoxocinone induces cell cycle arrest, apoptosis, and autophagy in non-small cell lung cancer
Xiaoqian Li, Xiaoju Cheng, Jie Wu, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Exosomal PD-L1 in cancer and other fields: recent advances and perspectives
Manman Lu, Yu Yang
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Recent progress of porphyrin metal-organic frameworks for combined photodynamic therapy and hypoxia-activated chemotherapy
Qiuyun Zhang, Xiaohui Wang, Jiayi Chen, et al.
Chemical Communications (2024) Vol. 60, Iss. 93, pp. 13641-13652
Closed Access | Times Cited: 5
Current trends in sensitizing immune checkpoint inhibitors for cancer treatment
Jing Wei, Wenke Li, Pengfei Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Immunotherapy targeting PD‑1/PD‑L1: A potential approach for the treatment of cancer bone metastases (Review)
Toru Hiraga
International Journal of Oncology (2024) Vol. 64, Iss. 4
Closed Access | Times Cited: 4
Advances of immune-checkpoint inhibition of CTLA-4 in pancreatic cancer
Ran Ni, Zhiming Hu, Ran Tao
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117430-117430
Open Access | Times Cited: 4
Immunomodulatory metal-based biomaterials for cancer immunotherapy
Kangzhi Yuan, Cai Zhang, Xiang-Ying Pan, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 249-268
Closed Access | Times Cited: 4
Editorial: Enhancing innate immunity in combination therapy for solid tumors
David Pejoski
Frontiers in Immunology (2025) Vol. 15
Open Access
Efficacy and safety of ondansetron orally soluble pellicle for preventing moderate- to high-emetic risk chemotherapy-induced nausea and vomiting
Lu Sun, Jia Ma, Yajuan Zhou, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Global research trends on biomarkers for cancer immunotherapy: Visualization and bibliometric analysis
Yuan Qiao, Dong Xie, Zhengxiang Li, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Dendrimer-Mediated Generation of a Metal-Phenolic Network for Antibody Delivery to Elicit Improved Tumor Chemo/Chemodynamic/Immune Therapy
Zhiqiang Wang, Yunqi Guo, Gaoming Li, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Paradoxical control of multifocal mammary oncogenesis by radiation therapy
Lorenzo Galluzzi, Aitziber Buqué
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Mesoporous dual-atom nanozyme induced cuproptosis and apoptosis for boosting immunogenic cell death along with reprogramming tumor immune-suppressive microenvironment
Yunhao Wang, Lei Ding, Zhan Lin, et al.
Chemical Engineering Journal (2025) Vol. 506, pp. 160294-160294
Closed Access
Page 1 - Next Page

Scroll to top